E koho iā mākou
Loaʻa iā JDK nā hale hana papa mua a me nā lako hoʻokele maikaʻi, e hōʻoiaʻiʻo ana i ka lako paʻa o nā kikowaena API.Hōʻoia ka hui ʻoihana i ka R&D o ka huahana.E kūʻē i nā mea ʻelua, ke ʻimi nei mākou iā CMO & CDMO ma ka mākeke kūloko a me ka honua.
Hōʻike huahana
Ua hōʻike ʻo Saliniso i ka ʻōlelo hoʻohiki maikaʻi loa i nā hoʻokolohua preclinical a me nā hoʻokolohua lapaʻau ma muli o kāna ʻano molekala kū hoʻokahi.No laila, ua huki nui ʻia ka manaʻo mai nā ʻoihana lapaʻau a me nā mea noiʻi.Me kāna ākea o nā noi kūpono, hāʻawi ʻo Saliniso i kahi ākea o nā pono therapeutic e hiki ke hoʻopōmaikaʻi i ke ola o nā poʻe he nui.
ʻO kekahi o nā hiʻohiʻona nui o Saliniso ʻo kona versatility.ʻO kona molecular structure hiki iā ia ke hoʻopaʻa i nā ʻano mea loaʻa, e lilo ia i kumu waiwai i ka mālama ʻana i nā maʻi like ʻole.ʻO nā maʻi neurological paha, ka maʻi maʻi a i ʻole nā maʻi autoimmune, ua hōʻoia ʻo Saliniso i kona pono i ka hāʻawi ʻana i nā hopena i manaʻo ʻia no nā kūlana olakino like ʻole.
Ma kahi o kāna versatility, loaʻa iā Saliniso ka bioavailability maikaʻi loa a me nā waiwai pharmacokinetic.Mālama kēia i ka hoʻopili pono ʻana o ka pūhui a hoʻohele ʻia i ke kino holoʻokoʻa, e hoʻonui ana i kona hiki ke therapeutic.Eia kekahi, ua hana ʻia nā noiʻi nui e hōʻoia i ka palekana o Saliniso a me ka ʻai kūpono no nā maʻi.
